Flavonoid components in Scutellaria baicalensis inhibit nicotine-induced proliferation, metastasis and lung cancer-associated inflammation in vitro

International Journal of Oncology

Volumn 44, Issue 5, 2014, Pages 1561-1570

  Gong, Wei Y I ^a   Wu, Jin Feng ^a   Liu, Bao Jun ^a   Zhang, Hong Ying ^a   Cao, Y U Xue ^a   Sun, Jing ^a   Lv, Y U Bao ^a   Wu, Xiao ^a   Dong, Jing Cheng ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Inflammation; Lung cancer; Metastasis; Nicotine; Scutellaria baicalensis

Indexed keywords

BAICALEIN; BAICALIN; CASPASE 3; GELATINASE A; GELATINASE B; I KAPPA B ALPHA; INTERLEUKIN 6; MESSENGER RNA; NICOTINE; PROTEIN BAX; PROTEIN BCL 2; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; WOGONIN;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; LUNG CANCER; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SCUTELLARIA BAICALENSIS; SUPERNATANT; TUMOR MICROENVIRONMENT; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; FLAVANONES; FLAVONOIDS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INFLAMMATION; LUNG NEOPLASMS; NEOPLASM METASTASIS; NICOTINE; PLANT EXTRACTS; SCUTELLARIA BAICALENSIS;

EID: 84899113430     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2014.2320     Document Type: Article

References (35)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
2. Chen W, Zhang S and Zou X: Estimation and projection of lung cancer incidence and mortality in China. Zhongguo Fei Ai Za Zhi 13: 488-493, 2010 (In Chinese).
3. Hecht SS: Cigarette smoking and lung cancer: chemical mechanisms and approaches to prevention. Lancet Oncol 3: 461-469, 2002.
4. Zhang J, Ou JX and Bai CX: Tobacco smoking in China: prevalence, disease burden, challenges and future strategies. Respirology 16: 1165-1172, 2011.
5. Egleton RD, Brown KC and Dasgupta P: Nicotinic acetylcholine receptors in cancer: multiple roles in proliferation and inhibition of apoptosis. Trends Pharmacol Sci 29: 151-158, 2008.
6. Thunnissen FB: Acetylcholine receptor pathway and lung cancer. J Thorac Oncol 4: 943-946, 2009.
7. Maneckjee R and Minna JD: Opioid and nicotine receptors affect growth regulation of human lung cancer cell lines. Proc Natl Acad Sci USA 87: 3294-3298, 1990.
8. Tournier JM and Birembaut P: Nicotinic acetylcholine receptors and predisposition to lung cancer. Curr Opin Oncol 23: 83-87, 2011.
9. Lam DC, Girard L, Ramirez R, et al: Expression of nicotinic acetylcholine receptor subunit genes in non-small-cell lung cancer reveals differences between smokers and nonsmokers. Cancer Res 67: 4638-4647, 2007. (Pubitemid 46910168)
10. Kelly PN and Strasser A: The role of Bcl-2 and its pro-survival relatives in tumourigenesis and cancer therapy. Cell Death Differ 18: 1414-1424, 2011.
11. Leber B, Geng F, Kale J and Andrews DW: Drugs targeting Bcl-2 family members as an emerging strategy in cancer. Expert Rev Mol Med 12: e28, 2010.
12. Xin M and Deng X: Nicotine inactivation of the proapoptotic function of Bax through phosphorylation. J Biol Chem 280: 10781-10789, 2005. (Pubitemid 40395941)
13. Dasgupta P, Rizwani W, Pillai S, et al: Nicotine induces cell proliferation, invasion and epithelial-mesenchymal transition in a variety of human cancer cell lines. Int J Cancer 124: 36-45, 2009.
14. Davis R, Rizwani W, Banerjee S, et al: Nicotine promotes tumor growth and metastasis in mouse models of lung cancer. PLoS One 4: e7524, 2009.
15. Nelson AR, Fingleton B, Rothenberg ML and Matrisian LM: Matrix metalloproteinases: biologic activity and clinical implications. J Clin Oncol 18: 1135-1149, 2000. (Pubitemid 30123793)
16. Bayramoglu A, Gunes HV, Metintas M, Degirmenci I, Mutlu F and Alatas F: The association of MMP-9 enzyme activity, MMP-9 C1562T polymorphism, and MMP-2 and -9 and TIMP-1, -2, -3, and -4 gene expression in lung cancer. Genet Test Mol Biomarkers 13: 671-678, 2009.
17. Herbst RS, Yano S, Kuniyasu H, et al: Differential expression of E-cadherin and type IV collagenase genes predicts outcome in patients with stage I non-small cell lung carcinoma. Clin Cancer Res 6: 790-797, 2000. (Pubitemid 30159331)
18. Klein G, Vellenga E, Fraaije MW, Kamps WA and de Bont ES: The possible role of matrix metalloproteinase (MMP)-2 and MMP-9 in cancer, e.g. acute leukemia. Crit Rev Oncol Hematol 50: 87-100, 2004. (Pubitemid 38638736)
19. Zong Y, Zhang ST and Zhu ST: Nicotine enhances migration and invasion of human esophageal squamous carcinoma cells which is inhibited by nimesulide. World J Gastroenterol 15: 2500-2505, 2009.
20. Lee HZ, Leung HW, Lai MY and Wu CH: Baicalein induced cell cycle arrest and apoptosis in human lung squamous carcinoma CH27 cells. Anticancer Res 25: 959-964, 2005. (Pubitemid 40546869)
21. Leung HW, Yang WH, Lai MY, Lin CJ and Lee HZ: Inhibition of 12-lipoxygenase during baicalein-induced human lung nonsmall carcinoma H460 cell apoptosis. Food Chem Toxicol 45: 403-411, 2007. (Pubitemid 46188376)
22. Du G, Han G, Zhang S, et al: Baicalin suppresses lung carcinoma and lung metastasis by SOD mimic and HIF-1alpha inhibition. Eur J Pharmacol 630: 121-130, 2010.
23. Li-Weber M: New therapeutic aspects of flavones: the anti-cancer properties of Scutellaria and its main active constituents Wogonin, Baicalein and Baicalin. Cancer Treat Rev 35: 57-68, 2009.
24. Lixuan Z, Jingcheng D, Wenqin Y, Jianhua H, Baojun L and Xiaotao F: Baicalin attenuates inflammation by inhibiting NF-kappaB activation in cigarette smoke induced inflammatory models. Pulm Pharmacol Ther 23: 411-419, 2010.
25. Li L, Bao H, Wu J, et al: Baicalin is anti-inflammatory in cigarette smoke-induced inflammatory models in vivo and in vitro: a possible role for HDAC2 activity. Int Immunopharmacol 13: 15-22, 2012.
26. Petty TL: Are COPD and lung cancer two manifestations of the same disease? Chest 128: 1895-1897, 2005.
27. Yang IA, Relan V, Wright CM, et al: Common pathogenic mechanisms and pathways in the development of COPD and lung cancer. Expert Opin Ther Targets 15: 439-456, 2011.
28. Takahashi H, Ogata H, Nishigaki R, Broide DH and Karin M: Tobacco smoke promotes lung tumorigenesis by triggering IKKbeta- and JNK1-dependent inflammation. Cancer Cell 17: 89-97, 2010.
29. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25: 402-408, 2001. (Pubitemid 34164012)
30. Karunagaran D, Joseph J and Kumar TR: Cell growth regulation. Adv Exp Med Biol 595: 245-268, 2007.
31. Fennell DA: Caspase regulation in non-small cell lung cancer and its potential for therapeutic exploitation. Clin Cancer Res 11: 2097-2105, 2005.
32. Steeg PS: Tumor metastasis: mechanistic insights and clinical challenges. Nat Med 12: 895-904, 2006.
33. Chandrashekar N, Selvamani A, Subramanian R, Pandi A and Thiruvengadam D: Baicalein inhibits pulmonary carcinogenesis-associated inflammation and interferes with COX-2, MMP-2 and MMP-9 expressions in-vivo. Toxicol Appl Pharmacol 261: 10-21, 2012.
34. Tauler J and Mulshine JL: Lung cancer and inflammation: interaction of chemokines and hnRNPs. Curr Opin Pharmacol 9: 384-388, 2009.
35. Puliyappadamba VT, Cheriyan VT, Thulasidasan AK, et al: Nicotine-induced survival signaling in lung cancer cells is dependent on their p53 status while its downregulation by curcumin is independent. Mol Cancer 9: 220, 2010.